Literature DB >> 8707736

Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.

S C Chen1, M L O'Donnell, S Gordon, G L Gilbert.   

Abstract

The National Committee for Clinical Laboratory Standards reference broth macrodilution method for antifungal susceptibility testing was compared with the E test by testing 86 clinical isolates of Candida spp. and Cryptococcus neoformans. The MIC agreement rates for the two methods for Candida spp. were 73-89% within +/-1 doubling dilution and 87-100% within +/-2 dilutions. For C. neoformans, agreement within +/-1 dilution was > 70% for all the agents tested except fluconazole for which agreement was 35%. Our data support the further evaluation of the E test as an alternative method for antifungal susceptibility testing. However, E test MICs of fluconazole for C. neoformans, particularly C. neoformans var. gattii should be interpreted with caution, as falsely elevated MICs may occur.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707736     DOI: 10.1093/jac/37.2.265

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.

Authors:  W R Kirkpatrick; R K McAtee; S G Revankar; A W Fothergill; D I McCarthy; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.

Authors:  E Chryssanthou
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.

Authors:  A Szekely; E M Johnson; D W Warnock
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström; R N Jones
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.

Authors:  E Cantón; J Pemán; A Carrillo-Muñoz; A Orero; P Ubeda; A Viudes; M Gobernado
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test.

Authors:  A E Simor; G Goswell; L Louie; M Lee; M Louie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

8.  Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Karlsson; A Bolmström
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis.

Authors:  Milce Costa; Xisto Sena Passos; André Thiago Borges Miranda; Rosane Silva Carneiro de Araújo; Claudete Rodrigues Paula; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2004-01       Impact factor: 2.574

10.  Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.

Authors:  M J Maxwell; S A Messer; R J Hollis; D J Diekema; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.